2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer Report From the Fourth Ovarian Cancer Consensus Conference

被引:358
作者
Stuart, Gavin C. E. [1 ]
Kitchener, Henry [2 ]
Bacon, Monica
duBois, Andreas
Friedlander, Michael
Ledermann, Jonathan [2 ]
Marth, Christian
Thigpen, Tate
Trimble, Edward
机构
[1] NCIC CTG, Kingston, ON, Canada
[2] MRC NCRI, London, England
关键词
Ovarian cancer consensus conference; Gynecologic cancer intergroup;
D O I
10.1097/IGC.0b013e31821b2568
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer. This report provides the outcomes from the Fourth Ovarian Cancer Consensus Conference.
引用
收藏
页码:750 / 755
页数:6
相关论文
共 9 条
[1]  
ALLEN DG, 1993, ANN ONCOL, V4, P83
[2]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[3]   Advanced epithelial ovarian cancer:: 1998 consensus statements [J].
Berek, JS ;
Bertelsen, K ;
du Bois, A ;
Brady, MF ;
Carmichael, J ;
Eisenhauer, EA ;
Gore, M ;
Grenman, S ;
Hamilton, TC ;
Hansen, SW ;
Harper, PG ;
Horvath, G ;
Kaye, SB ;
Lück, HJ ;
Lund, B ;
McGuire, WP ;
Neijt, JP ;
Ozols, RF ;
Parmar, MKB ;
Piccart-Gebhart, MJ ;
van Rijswijk, R ;
Rosenberg, P ;
Rustin, GJS ;
Sessa, C ;
Thigpen, JT ;
Tropé, C ;
Tuxen, MK ;
Vergote, I ;
Vermorken, JB ;
Willemse, PHB .
ANNALS OF ONCOLOGY, 1999, 10 :87-92
[4]   Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC): A Gynecologic Oncology Group study [J].
Burger, R. A. ;
Brady, M. F. ;
Bookman, M. A. ;
Walker, J. L. ;
Homesley, H. D. ;
Fowler, J. ;
Monk, B. J. ;
Greer, B. E. ;
Boente, M. ;
Liang, S. X. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
[5]   2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) [J].
du Bois, A ;
Quinn, M ;
Thigpen, T ;
Vermorken, J ;
Avall-Lundqvist, E ;
Bookman, M ;
Bowtell, D ;
Brady, M ;
Casado, A ;
Cervantes, A ;
Eisenhauer, E ;
Friedlaender, M ;
Fujiwara, K ;
Grenman, S ;
Guastalla, JP ;
Harper, P ;
Hogberg, T ;
Kaye, S ;
Kitchener, H ;
Kristensen, G ;
Mannel, R ;
Meier, W ;
Miller, B ;
Neijt, JP ;
Oza, A ;
Ozols, R ;
Parmar, M ;
Pecorelli, S ;
Pfisterer, J ;
Poveda, A ;
Provencher, D ;
Pujade-Lauraine, E ;
Randall, M ;
Rochon, J ;
Rustin, G ;
Sagae, S ;
Stehman, F ;
Stuart, G ;
Trimble, E ;
Vasey, P ;
Vergote, I ;
Verheijen, R ;
Wagner, U .
ANNALS OF ONCOLOGY, 2005, 16 :7-12
[6]   Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial [J].
Katsumata, Noriyuki ;
Yasuda, Makoto ;
Takahashi, Fumiaki ;
Isonishi, Seiji ;
Jobo, Toshiko ;
Aoki, Doisuke ;
Tsuda, Hiroshi ;
Sugiyama, Toru ;
Kodama, Shoji ;
Kimura, Eizo ;
Ochiai, Kazunori ;
Noda, Kiichiro .
LANCET, 2009, 374 (9698) :1331-1338
[7]  
Perren T, 2010, ANN ONCOL, V21, P2
[8]   History, scope and methodology of the 3rd International Consensus Workshop on Ovarian Cancer 2004 [J].
Quinn, M ;
Avall-Lundqvist, E ;
du Bois, A ;
Vermorken, J ;
Parmar, M ;
Pfisterer, J ;
Stuart, G ;
Thigpen, T ;
Neijt, J .
ANNALS OF ONCOLOGY, 2005, 16 :5-6
[9]   Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer [J].
Vergote, Ignace ;
Trope, Claes G. ;
Amant, Frederic ;
Kristensen, Gunnar B. ;
Ehlen, Tom ;
Johnson, Nick ;
Verheijen, Rene H. M. ;
van der Burg, Maria E. L. ;
Lacave, Angel J. ;
Panici, Pierluigi Benedetti ;
Kenter, Gemma G. ;
Casado, Antonio ;
Mendiola, Cesar ;
Coens, Corneel ;
Verleye, Leen ;
Stuart, Gavin C. E. ;
Pecorelli, Sergio ;
Reed, Nick S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10) :943-953